FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (68)
2024
-
Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)
ESMO Open, Vol. 9, Núm. 3
-
Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document
Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78
2023
-
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057
-
Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Preconfigured analytical profiles for the management of patients with heart failure: a consensus-driven study
REC: CardioClinics, Vol. 58, Núm. 3, pp. 219-227
-
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials
JAMA Oncology, Vol. 9, Núm. 4, pp. 490-499
-
Selection of the best of 2022 in arrhythmias and cardiac pacing
REC: CardioClinics, Vol. 58, pp. S35-S41
2022
-
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*
British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969
-
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
eBioMedicine, Vol. 75
-
Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study
Minerva Anestesiologica, Vol. 88, Núm. 4, pp. 259-271
-
FACTOR CONVERGENCE AND PREDICTIVE ANALYSIS OF THE FIVE FACTOR AND ALTERNATIVE FIVE FACTOR PERSONALITY MODELS WITH THE FIVE-FACTOR PERSONALITY INVENTORY FOR ICD-11 (FFICD)
Journal of Personality Disorders, Vol. 36, Núm. 3, pp. 296-319
-
One-year mortality after ICU admission due to COVID-19 infection
Intensive Care Medicine
-
Selection of the best of 2021 in valvular heart diseases
REC: CardioClinics, Vol. 57, pp. S48-S53
-
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study
Future oncology (London, England), Vol. 18, Núm. 33, pp. 3677-3688
-
Treatable traits in the NOVELTY study
Respirology, Vol. 27, Núm. 11, pp. 929-940
2021
-
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 858-871
-
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
Scientific Reports, Vol. 11, Núm. 1
-
Cohort profile: The Spanish Early-onset Colorectal Cancer (SECOC) cohort: A multicentre cohort study on the molecular basis of colorectal cancer among young individuals in Spain
BMJ Open, Vol. 11, Núm. 12